SEROQUEL XR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Seroquel Xr, and when can generic versions of Seroquel Xr launch?
Seroquel Xr is a drug marketed by Astrazeneca and is included in one NDA.
The generic ingredient in SEROQUEL XR is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Seroquel Xr
A generic version of SEROQUEL XR was approved as quetiapine fumarate by ACCORD HLTHCARE on March 27th, 2012.
Summary for SEROQUEL XR
Recent Clinical Trials for SEROQUEL XR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ain Shams University | N/A |
University of Miami | Phase 4 |
Alzheimer's Association | Phase 4 |
Pharmacology for SEROQUEL XR
Drug Class | Atypical Antipsychotic |
Anatomical Therapeutic Chemical (ATC) Classes for SEROQUEL XR
Paragraph IV (Patent) Challenges for SEROQUEL XR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SEROQUEL XR | Extended-release Tablets | quetiapine fumarate | 150 mg | 022047 | 1 | 2008-11-17 |
SEROQUEL XR | Extended-release Tablets | quetiapine fumarate | 50 mg | 022047 | 1 | 2008-10-17 |
SEROQUEL XR | Extended-release Tablets | quetiapine fumarate | 400 mg | 022047 | 1 | 2008-06-18 |
SEROQUEL XR | Extended-release Tablets | quetiapine fumarate | 200 mg and 300 mg | 022047 | 1 | 2008-06-12 |
US Patents and Regulatory Information for SEROQUEL XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-001 | May 17, 2007 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-003 | May 17, 2007 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-005 | Aug 11, 2008 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-002 | May 17, 2007 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-004 | May 17, 2007 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SEROQUEL XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-004 | May 17, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-003 | May 17, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-005 | Aug 11, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-005 | Aug 11, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-001 | May 17, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | SEROQUEL XR | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 022047-003 | May 17, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SEROQUEL XR
See the table below for patents covering SEROQUEL XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 84569 | PROCESSO PARA A PREPARACAO DE TIAZEPINAS E DE COMPOSICOES FARMACEUTICAS QUE OS CONTEM | ⤷ Try a Trial |
United Kingdom | 8706949 | ⤷ Try a Trial | |
Finland | 86059 | ⤷ Try a Trial | |
Bulgaria | 61365 | ⤷ Try a Trial | |
Japan | S638378 | DIBENZOTHIAZEPINE COMPOUND, MANUFACTURE AND PHARMACEUTICAL COMPOSITION HAVING ANTIPSYCHOTIC AND NEUROLEPTIC ACTIVITY | ⤷ Try a Trial |
Australia | 7045987 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SEROQUEL XR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0240228 | 9/2000 | Austria | ⤷ Try a Trial | PRODUCT NAME: QUETIAPIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ZULAESSIGEN SALZES; NAT. REGISTRATION NO/DATE: 1-23460, 1-23461 1-23463 20000113; FIRST REGISTRATION: GB 12619/0112 - 12619/0114 19970731 |
0240228 | SPC/GB97/086 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: QUETIAPINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY-ACCEPTABLE SALT; REGISTERED: UK 12619/0112 19970731; UK 12619/0113 19970731; UK 12619/0114 19970731 |
0240228 | C980022 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: QUETIAPINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZOUT, IN HET BIJZONDER QUETIAPINEFUMARAAT; NAT. REGISTRATION NO/DATE: RVG 20826 - RVG 20828 19980427; FIRST REGISTRATION: GB PL 12619/0112 - PL 12619/0114 19970731 |
0240228 | 2000C/015 | Belgium | ⤷ Try a Trial | PRODUCT NAME: QUETIAPINE FUMARAT (EQUIV. MET 25MG QUETIAPINE BASE); REGISTRATION NO/DATE: 624 S 309 F 3 20000207; FIRST REGISTRATION: GB PL 12619/0113 19970731 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |